Tumor cells (i.e., Keratin positive) single cells clustered according to the clinical annotation that was extracted from the clinical database of the corresponding tumor (HER2+ [regardless of HR status], HR+/HER2− and HR−/HER2−) and, as expected, the immune cells were randomly distributed (Supplementary Fig. 6A). The gene discussed is ERBB2; the disease is neoplasm.